Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 1467 entries
View as:

A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06418607 Org: User:
Start: 06/23/20 End: 07/13/20 Due: 07/13/21

Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01266512 Org: User:
Start: 01/31/11 End: 03/31/14 Due: 03/31/15

Efficacy and Safety of Rimonabant as an Aid to Maintenance of Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT00459173 Org: User:
Start: 11/30/02 End: 09/30/05 Due: 09/30/06

Glulisine + Lantus in Type I Patients

Phase: N/A Priority: Normal
NCT ID: NCT00546702 Org: User:
Start: 09/30/04 End: 02/28/05 Due: 02/28/06

Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00308503 Org: User:
Start: 02/28/06 End: 08/31/07 Due: 08/31/08

Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Smoking Cessation (STRATUS US)

Phase: N/A Priority: Normal
NCT ID: NCT00358228 Org: User:
Start: 09/30/02 End: 08/31/03 Due: 08/31/04

Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study

Phase: N/A Priority: Normal
NCT ID: NCT00575913 Org: User:
Start: 09/30/03 End: 03/31/05 Due: 03/31/06

A National Study in Patients With Unexplained Splenomegaly

Phase: N/A Priority: Normal
NCT ID: NCT04430881 Org: User:
Start: 09/30/15 End: 04/27/21 Due: 04/27/22

An Observational Study on Teriflunomide-exposed Pregnancies

Phase: N/A Priority: Normal
NCT ID: NCT03198351 Org: User:
Start: 04/25/13 End: 06/13/23 Due: 06/13/24

Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00387907 Org: User:
Start: 10/31/06 End: 03/31/08 Due: 03/31/09

Colorectal Cancer RECHALLENGE

Phase: N/A Priority: Normal
NCT ID: NCT00988897 Org: User:
Start: 10/31/09 End: 05/31/12 Due: 05/31/13

An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00629551 Org: User:
Start: 02/29/08 End: 02/28/09 Due: 02/28/10

Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01863888 Org: User:
Start: 10/31/13 End: 01/31/15 Due: 01/31/16

Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)

Phase: N/A Priority: Normal
NCT ID: NCT01146652 Org: User:
Start: 06/21/10 End: 12/31/20 Due: 12/31/21

CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00129870 Org: User:
Start: 02/28/05 End: 12/31/07 Due: 12/31/08

Docetaxel in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00312208 Org: User:
Start: 11/30/01 End: 10/31/13 Due: 10/31/14

Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00174681 Org: User:
Start: 04/30/03 End: - Due: -

Sotagliflozin Bioequivalence Study

Phase: N/A Priority: Normal
NCT ID: NCT03211195 Org: User:
Start: 06/29/17 End: 08/22/17 Due: 08/22/18

Dupilumab Skin Barrier Function Study in Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04447417 Org: User:
Start: 07/16/20 End: 06/17/21 Due: 06/17/22

A Study of the Safety and Pharmacokinetics of SAR245408 Tablets in Patients With Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01943838 Org: User:
Start: 10/31/13 End: 02/28/15 Due: 02/28/16

Dupilumab in Chinese Adult Participants With CRSwNP

Phase: N/A Priority: Normal
NCT ID: NCT05878093 Org: User:
Start: 05/16/23 End: 11/28/24 Due: 11/28/25

Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT00437463 Org: User:
Start: 07/31/04 End: 09/30/10 Due: 09/30/11

Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00127803 Org: User:
Start: 07/31/05 End: 03/31/06 Due: 03/31/07

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01121848 Org: User:
Start: 07/31/10 End: 10/31/13 Due: 10/31/14

Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood Glucose

Phase: N/A Priority: Normal
NCT ID: NCT00405808 Org: User:
Start: 12/31/06 End: 02/28/09 Due: 02/28/10